Guselkumab 100mg/ml, Inj Tildrakizumab
Indian Army · Lucknow · Pharmaceuticals · open
Key facts
- Tender value: ₹36.0L
- EMD: ₹39K
- Published: 19 Aug 2026
- Closing date: 29 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of Guselkumab 100mg/ml and Inj Tildrakizumab with a total quantity of 60 units, issued by Indian Army under Ministry of Defence, Department of Military Affairs. Bid validity is 180 days from the end date, with bid opening scheduled for 29-08-2026 at 15:30. The estimated bid value is approximately 3,599,980 INR. The tender includes EMD and ePBG requirements, and preferences for MII and MSE vendors.
Eligibility & requirements
- Experience required: 3 years
- Past performance: 50%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience Certificate, Turnover Certificate, OEM Authorization, OEM Annual Turnover, Additional Documents, Compliance of BoQ
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Guselkumab 100mg/ml, Inj Tildrakizumab — Qty: 60 unit
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals